Creative Biolabs Announces iPSC Services for Neurological Disease Research
New York, USA – October 30, 2023 – Induced pluripotent stem cells (iPSCs) serve as powerful tools in understanding the pathophysiology of neurological diseases. The key advantage of iPSCs lies in their ability to be reprogrammed from somatic cells, enabling researchers to develop patient-specific cell lines. This ensures the preservation of individual genetic backgrounds and disease-specific phenotypes, thereby producing more accurate disease models. With iPSC technology, Creative Biolabs offers a comprehensive suite of services, including stem cell reprogramming and iPSC genome editing, specifically aimed at advancing research into neurological diseases.
“The application of stem cell reprogramming in neurological research helps mimic the human neural environment in lab conditions, providing a more accurate perspective of neurological disease pathology,” stated a scientist at Creative Biolabs. “Moreover, iPSCs possess unlimited self-renewal potential and can differentiate into any cell type, including neurons and glial cells. This offers opportunities for studying neurodegenerative disorders like Parkinson’s disease, Alzheimer’s disease, and ALS in ways animal models cannot.”
With extensive experience in neuroscience modeling research, Creative Biolabs can provide a variety of neurological disease modeling services, including but not limited to blood-brain barrier models and neuroscience ex vivo models, aimed at satisfying hundreds of customers’ demands in neuroscience research.
Further enhancing its innovative offerings, Creative Biolabs integrates the revolutionary technique of iPSC genome editing, allowing researchers to add, remove, or alter genetic material at particular locations in the genome. This technique enables the study of the link between genetic factors and the onset of neurological diseases, paving the way for the design of targeted, effective treatments.
“For many years, neurological disease research has been hampered by the lack of predictive models that truly replicate the human brain,” said the senior researcher at Creative Biolabs. “Our iPSC services and modeling services will provide researchers with the critical support they need for breakthroughs in this vital field.”
To learn more about neuroscience modeling and iPSC services at Creative Biolabs, please visit https://www.creative-biolabs.com/stem-cell-therapy.
About Creative Biolabs
Creative Biolabs is a leading biotech company focused on offering problem-solving solutions and expert assistance to the global scientific community in drug discovery and development. With a mission to build a unique platform that provides comprehensive drug discovery services and products, Creative Biolabs is dedicated to delivering the most reliable and effective solutions for customers worldwide.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/stem-cell-therapy
